141 related articles for article (PubMed ID: 18439923)
1. [Dopamine dysregulation syndrome in Parkinson's disease].
Borg M; Bayreuther C
Rev Neurol (Paris); 2008 Apr; 164(4):310-21. PubMed ID: 18439923
[TBL] [Abstract][Full Text] [Related]
2. Dopamine agonists and therapy compliance.
Grosset D
Neurol Sci; 2008 Dec; 29 Suppl 5():S375-6. PubMed ID: 19381766
[TBL] [Abstract][Full Text] [Related]
3. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
Fenu S; Wardas J; Morelli M
Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
[TBL] [Abstract][Full Text] [Related]
4. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Bayard S; Cochen De Cock V; Dauvillers Y
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
[TBL] [Abstract][Full Text] [Related]
5. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
[TBL] [Abstract][Full Text] [Related]
6. Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for Parkinson disease (PD): a case report.
Knobel D; Aybek S; Pollo C; Vingerhoets FJ; Berney A
Cogn Behav Neurol; 2008 Sep; 21(3):187-9. PubMed ID: 18797262
[TBL] [Abstract][Full Text] [Related]
7. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.
Evans AH; Katzenschlager R; Paviour D; O'Sullivan JD; Appel S; Lawrence AD; Lees AJ
Mov Disord; 2004 Apr; 19(4):397-405. PubMed ID: 15077237
[TBL] [Abstract][Full Text] [Related]
8. Dopamine dysregulation syndrome in Parkinson's disease.
Evans AH; Lees AJ
Curr Opin Neurol; 2004 Aug; 17(4):393-8. PubMed ID: 15247533
[TBL] [Abstract][Full Text] [Related]
9. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
Merims D; Giladi N
Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
[TBL] [Abstract][Full Text] [Related]
10. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
11. [Motor symptoms in Parkinson disease].
Larsen JP; Beiske AG; Bekkelund SI; Dietrichs E; Tysnes OB; Vilming ST; Aasly JO
Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2068-71. PubMed ID: 18846123
[TBL] [Abstract][Full Text] [Related]
12. The rationale for continuous dopaminergic stimulation in advanced Parkinson's disease.
Nyholm D
Parkinsonism Relat Disord; 2007 Sep; 13 Suppl():S13-7. PubMed ID: 17707679
[TBL] [Abstract][Full Text] [Related]
13. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease.
Huisman E; Uylings HB; Hoogland PV
Mov Disord; 2004 Jun; 19(6):687-92. PubMed ID: 15197709
[TBL] [Abstract][Full Text] [Related]
14. Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study.
Bearn J; Evans A; Kelleher M; Turner K; Lees A
Drug Alcohol Depend; 2004 Dec; 76(3):305-10. PubMed ID: 15561481
[TBL] [Abstract][Full Text] [Related]
15. [Parkinson disease and the neuronal dopamine uptake complex].
Costentin J
Ann Pharm Fr; 1995; 53(4):145-54. PubMed ID: 7574268
[TBL] [Abstract][Full Text] [Related]
16. [Surgical treatment of Parkinson's disease as a supplement to pharmacological therapy].
Jabłońska B; Dabek J; Lepich T
Wiad Lek; 2006; 59(11-12):823-8. PubMed ID: 17427499
[TBL] [Abstract][Full Text] [Related]
17. Levodopa/dopamine replacement strategies in Parkinson's disease--future directions.
Olanow CW
Mov Disord; 2008; 23 Suppl 3():S613-22. PubMed ID: 18781663
[TBL] [Abstract][Full Text] [Related]
18. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation.
Romito LM; Contarino MF; Vanacore N; Bentivoglio AR; Scerrati M; Albanese A
Mov Disord; 2009 Mar; 24(4):557-63. PubMed ID: 19097175
[TBL] [Abstract][Full Text] [Related]
19. [Deep brain stimulation for Parkinson's disease and dystonia].
Yokochi F
Brain Nerve; 2009 Apr; 61(4):473-83. PubMed ID: 19378817
[TBL] [Abstract][Full Text] [Related]
20. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
Smith Y; Villalba R
Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
